Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer

Gram-positive bacterial infections are an important cause of morbidity and death among cancer patients, despite current therapy. In this case-control study, we evaluated the clinical outcomes and safety of telavancin in cancer patients with uncomplicated Gram-positive bloodstream infections (BSIs)....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrob Agents Chemother
Hauptverfasser: Chaftari, Anne-Marie, Hachem, Ray, Jordan, Mary, Garoge, Kumait, Al Hamal, Zainab, El Zakhem, Aline, Viola, George M., Granwehr, Bruno, Mulanovich, Victor, Gagel, Andrew, Reitzel, Ruth, Yousif, Ammar, Jiang, Ying, Raad, Issam
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2015
Schlagworte:
Clinical Therapeutics
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704239/
https://ncbi.nlm.nih.gov/pubmed/26482312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00617-15
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge